Testing effectiveness (Phase 2)Study completedNCT01242813
What this trial is testing
Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).
Who this might be right for
TNF-receptor Associated Periodic Syndromes (TRAPS)
Novartis Pharmaceuticals 20